Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03955432 · ClinicalTrials.gov registry record · NA
Long-term Cardiac Monitoring in Epilepsy
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03955432: Clinical Trial NA study, sponsored by Northwell Health.
NCT03955432 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03955432, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this research study to investigate, classify, and quantify chronic cardiac rhythm disorders in three groups of patients with epilepsy (intractable focal epilepsy, controlled focal epilepsy and symptomatic generalized epilepsy). Patients with epilepsy have a higher risk for cardiac complications than the general population. With this study, we aim to understand more about these potential complications in patients with epilepsy and assess if treatments for cardiac problems should be evaluated more carefully in patients with epilepsy.
Primary Outcome
Ratio of the total number of observed events divided by the number of person-days at risk in that group. Arrhythmias will be classified into different categories based on the observed data. "Arrhythmia of any type", as well as specific categories of arrhythmias will be analyzed separately.
Interventions
- DEVICE Reveal LINQ ICM System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-03-19 |
| Est. Completion | 2023-01-03 |
| Phase | NA |
Why NCT03955432 stopped before completion
NCT03955432 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Reveal LINQ ICM System is the first listed.
NCT03955432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03955432 about?
NCT03955432 is a clinical study titled "Long-term Cardiac Monitoring in Epilepsy". The purpose of this research study to investigate, classify, and quantify chronic cardiac rhythm disorders in three groups of patients with epilepsy (intractable focal epilepsy, controlled focal epilepsy and symptomatic generalized epilepsy). Patients with epilepsy have a higher risk for cardiac com...
What is the current status of trial NCT03955432?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2019-03-19. Estimated completion is 2023-01-03.
What interventions are being tested in trial NCT03955432?
The interventions under investigation include: Reveal LINQ ICM System (DEVICE).
Who is sponsoring clinical trial NCT03955432?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03955432's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI